Verily Health: AI-Native Precision Health Platform — Company Profile
A structured profile of Verily Health Inc., the AI-native precision health platform company that became formally independent from Alphabet in March 2026, covering its Verily Pre platform architecture, product portfolio (Lightpath, Sightline, Viewpoint, Verily Me), validated clinical partnerships, funding history, and known limitations — for health system administrators, CIOs, clinical researchers, and procurement teams evaluating the company's capabilities and strategic position.
- Tool
- Verily Health: AI-Native Precision Health Platform — Company Profile
- Published
- Updated
FDA clearance status
Not reported
A regulatory fact, reported separately from the evidence verdict.
Risk-of-bias verdict
Not yet rated
Risk-of-bias scorecard
- Study design
- Not reported in the cited evidence
- External / prospective validation
- Not reported in the cited evidence
- Key performance metric
- Not reported in the cited evidence
- Overall rating
- Not yet rated
Current regulatory status
Informational only — read the full disclaimer. This content supports procurement and research judgment, not clinical care decisions.